March is National Colorectal Cancer Awareness Month
March is Colorectal Cancer Awareness Month. This month, Charleston Oncology recognizes the importance of spreading awareness surrounding the disease.
Colorectal cancer is the third most common cancer diagnosed in men and women in the United States. The lifetime risk of developing colorectal cancer is around 1 in 23 for men and 1 in 26 for women; however, this number can differ depending on an individual’s risk factors.
Provider Gene B. Saylors, MD, encourages those 45 years of age and those with a family history of colorectal cancer to complete screenings routinely. “It’s a highly curable illness if caught early, and we can save lives by pursuing active screening,” according to Saylors.
For more information or to schedule an appointment or call one of our locations to schedule an evaluation.
Send UsA Message
Tips for Diagnosing Breast Cancer Early
Dr. Shelly Shand shares important tips for diagnosing breast cancer early and the latest advancements in breast cancer.
Staying Aware for Breast Cancer Awareness Month
Staying Aware for Breast Cancer Awareness monthCharleston Oncology is proud to sponsor Staying Aware for Breast Cancer Awareness month in conjunction with WCIV News Channel 4. We continue to partner with our community to ensure that every woman has the best chance of...
Early-Stage Breast Cancer Characteristics and Treatment Options
Early-Stage Breast Cancer Characteristics and Treatment OptionsA rise in early-stage breast cancer diagnosis may result from better screening technology and a raised awareness of the importance of annual mammograms. An early-stage breast cancer diagnosis is contained...
Game Changing Neoadjuvant Lung Trial Enrolls the Most People in the World
Charleston Oncology’s Clinical Trials most recent non–small cell lung cancer trial enrolled the most people in the world. Gene Saylors, MD, oncologist and hematologist at Charleston Oncology, will present the positive findings at the American Association for Cancer Research 2022 Annual Meeting. “When administering a new trial, we are always cautiously optimistic,” says Dr. Gene Saylors. “The positive results of this Neoadjuvant Lung Trial resulted in rapid FDA approval due to its impressive outcomes.”
Lowcountry doctors, patients helped secure ‘game-changer’ cancer treatment approval
Clinical trials for a newly-approved cancer treatment for lung cancer in the Lowcountry helped get the drug ready for people around the world, Lowcountry medical officials say.
Lowcountry Breast Cancer Survivors On Finding The Right Oncology Practice
How should one go about finding the right oncology practice? We interviewed ten Lowcountry breast cancer patients to get their perspectives and advice.
